{"id":432,"date":"2026-03-04T12:58:01","date_gmt":"2026-03-04T12:58:01","guid":{"rendered":"https:\/\/forgetnow.com\/index.php\/2026\/03\/04\/ted-lasso-star-kola-bokinni-reveals-fathers-dementia-diagnosis-champions-research-for-a-cure\/"},"modified":"2026-03-04T12:58:01","modified_gmt":"2026-03-04T12:58:01","slug":"ted-lasso-star-kola-bokinni-reveals-fathers-dementia-diagnosis-champions-research-for-a-cure","status":"publish","type":"post","link":"https:\/\/forgetnow.com\/index.php\/2026\/03\/04\/ted-lasso-star-kola-bokinni-reveals-fathers-dementia-diagnosis-champions-research-for-a-cure\/","title":{"rendered":"Ted Lasso Star Kola Bokinni Reveals Father\u2019s Dementia Diagnosis, Champions Research for a Cure"},"content":{"rendered":"

In a poignant and deeply personal revelation, Kola Bokinni, the acclaimed star of Apple TV+\u2019s Emmy and SAG Award-winning series Ted Lasso<\/em>, has publicly shared the devastating impact of dementia on his family. His candid disclosure, made to raise critical awareness and galvanize support for Alzheimer\u2019s Research UK\u2019s relentless pursuit of a cure, casts a spotlight on a condition affecting millions globally. Bokinni, 31, known for his role as AFC Richmond captain Isaac McAdoo, unveiled that his father, Taiwo Bokinni, 81, is living with vascular dementia and now requires comprehensive round-the-clock care.<\/p>\n

The actor\u2019s decision to share his family\u2019s journey coincides with Alzheimer\u2019s Research UK\u2019s powerful new campaign film, Change The Ending<\/em>, which launched globally on World Alzheimer\u2019s Day (Thursday, September 21). Voiced by Oscar-winning actor Olivia Colman, the campaign starkly illustrates the profound ways dementia can strip individuals of their cherished futures and underscores the urgent need for medical breakthroughs. Bokinni\u2019s personal narrative serves as a potent reminder of the human stories behind the statistics, offering a compelling call to action for increased research funding and public engagement.<\/p>\n

A Personal Battle: Taiwo Bokinni\u2019s Vascular Dementia Diagnosis<\/strong><\/p>\n

Kola Bokinni recounted the initial, unsettling signs of his father\u2019s condition, which began to manifest approximately four years ago. This period overlapped with the filming of the inaugural season of Ted Lasso<\/em>, a show that would later achieve immense critical and popular success for its heartwarming narrative and empathetic characters. The contrast between the burgeoning joy of his professional life and the growing concern in his personal sphere highlights the insidious nature of dementia, often creeping in subtly before taking a firm hold.<\/p>\n

\u201cI first noticed something wasn\u2019t right about four years ago when I was filming the first series of Ted Lasso,\u201d Kola Bokinni stated, detailing the subtle yet significant shifts in his father\u2019s behavior. Taiwo Bokinni, described by his son as a meticulously organised and image-proud individual with a rigid daily routine, began exhibiting uncharacteristic deviations. Kola observed instances where his father would forget to eat, a stark departure from his usual habits. More alarmingly, he would sometimes find his father still in bed at noon, a stark contrast to his customary 8 am rise. These early indicators, while concerning, initially baffled the family, as the specific nature of the problem remained elusive.<\/p>\n

The gravity of the situation became undeniable when Taiwo Bokinni displayed clear signs of disorientation and memory impairment. Kola recalled a particularly distressing incident: \u201cI knew things were seriously wrong when he thought my cousin was my girlfriend, but I had no idea what it could be.\u201d This moment of profound confusion served as a catalyst for seeking professional medical evaluation. Following a series of tests, the family received the diagnosis: vascular dementia.<\/p>\n

Understanding Vascular Dementia<\/strong><\/p>\n

Vascular dementia, the second most common type of dementia after Alzheimer\u2019s disease, accounts for approximately 15-20% of all dementia cases. It is caused by reduced blood flow to the brain, which damages and eventually kills brain cells. This impaired blood flow often results from a series of small strokes (mini-strokes) or changes in the small blood vessels deep within the brain. Unlike Alzheimer\u2019s, which often presents with gradual memory loss, vascular dementia can have a more stepwise progression, with symptoms sometimes appearing suddenly after a stroke or deteriorating in noticeable stages.<\/p>\n

Symptoms can vary widely depending on the part of the brain affected, but commonly include problems with planning, organizing, problem-solving, and decision-making, as well as slowed thinking, difficulty concentrating, and issues with memory recall. Emotional changes, such as apathy, depression, or increased irritability, are also common. Taiwo Bokinni\u2019s symptoms, including altered routine, forgetfulness, and confusion, are consistent with the presentation of vascular dementia, which often impacts executive functions and cognitive processing speed. The progression of the disease to a point where round-the-clock care is necessary underscores the severe and debilitating nature of the condition, placing immense strain on both the individual living with dementia and their family caregivers.<\/p>\n

"Change The Ending": A Campaign for Hope<\/strong><\/p>\n

Kola Bokinni\u2019s decision to share his story is intrinsically linked to his support for Alzheimer\u2019s Research UK\u2019s new Change The Ending<\/em> campaign. This initiative aims to confront the harsh realities of dementia head-on, illustrating how the condition tragically robs individuals of their \u201chappily ever afters\u201d and the fundamental aspects of their identity. By depicting the devastating trajectory of dementia, the campaign seeks to rally public support for intensified research efforts, positioning scientific breakthroughs as the ultimate means to alter this grim narrative.<\/p>\n

Alzheimer\u2019s Research UK, the UK\u2019s leading dementia research charity, is dedicated to funding pioneering research into the causes, treatments, and preventions of all forms of dementia. Established with the vision of a world free from the fear, harm, and heartbreak of dementia, the charity invests millions annually into innovative projects, striving to accelerate the discovery of disease-modifying therapies. Their mission encompasses not only Alzheimer\u2019s disease but also vascular dementia, frontotemporal dementia, dementia with Lewy bodies, and other less common forms.<\/p>\n

The involvement of prominent figures like Kola Bokinni and Olivia Colman lends significant weight to the campaign. Colman, an Oscar-winning actress revered for her powerful performances, lends her distinctive voice to the Change The Ending<\/em> film, amplifying its emotional resonance and reach. Celebrity advocacy plays a crucial role in destigmatizing complex health conditions, fostering public empathy, and translating awareness into tangible support, including donations and policy engagement. Their voices help to humanize the scientific quest, connecting the abstract concept of research to the very real and painful experiences of families like the Bokinnis.<\/p>\n

Kola Bokinni articulated the profound personal toll of the disease, stating, \u201cMy dad was the life and soul of the party. He was so generous and always really happy, but sadly dementia has taken all that away from him. Dementia doesn\u2019t just affect the person who has the diagnosis, it affects the whole family. It\u2019s so hard to sit back and watch someone become a shell of their former self.\u201d His heartfelt testimony resonates with countless families worldwide grappling with similar challenges, emphasizing the collective burden and shared heartbreak. Despite the personal pain, Bokinni expressed a powerful hope for the future: \u201cWhile I know it\u2019s too late for my dad, I want to do everything I can to change the ending for others because no one\u2019s life should ever end this way. I\u2019m proud to stand with Alzheimer\u2019s Research UK, because I know with our support, they will find the cure we\u2019re all desperately waiting on.\u201d<\/p>\n

The Global Burden of Dementia: A Statistical Overview<\/strong><\/p>\n

Dementia represents one of the most significant global health challenges of the 21st century. According to the World Health Organization (WHO), over 55 million people worldwide are living with dementia, and there are nearly 10 million new cases every year. Alzheimer’s disease is the most common form, contributing to 60-70% of cases, followed by vascular dementia. The number of people living with dementia is projected to rise to 78 million by 2030 and 139 million by 2050, primarily due to the aging global population.<\/p>\n

In the UK alone, over 900,000 people are living with dementia, a number predicted to surpass one million by 2024. The economic cost of dementia in the UK is staggering, estimated at \u00a334.7 billion annually. This figure encompasses direct healthcare costs, social care costs, and the invaluable, often unpaid, contributions of family caregivers. Vascular dementia, specifically, affects around 150,000 people in the UK. Risk factors for vascular dementia often overlap with those for heart disease and stroke, including high blood pressure, high cholesterol, diabetes, smoking, and obesity. Managing these conditions is crucial for prevention, yet once symptoms manifest, the progressive decline remains a formidable challenge without disease-modifying treatments.<\/p>\n

These statistics underscore not only the immense individual suffering but also the profound societal and economic burden of dementia. The condition places significant strain on healthcare systems, social services, and the broader economy, necessitating a concerted global effort to accelerate research into effective treatments and ultimately, a cure.<\/p>\n

Frontiers of Research: New Horizons in Treatment<\/strong><\/p>\n

The landscape of dementia research, while historically challenging, is currently experiencing a period of unprecedented excitement and progress. For decades, the pharmaceutical industry struggled to develop effective treatments for dementia, leading to a perception of the condition as intractable. However, recent scientific breakthroughs have injected renewed optimism into the field.<\/p>\n

In particular, advancements in Alzheimer\u2019s disease research have shown promising results. The development of amyloid-targeting monoclonal antibodies, such as aducanumab, lecanemab, and donanemab, represents a significant paradigm shift. These treatments aim to remove amyloid plaques\u2014a hallmark protein accumulation in the brains of people with Alzheimer’s\u2014and have demonstrated the ability to slow cognitive decline in the early stages of the disease. While these treatments are not a cure and are primarily for Alzheimer\u2019s, their success validates the amyloid hypothesis and paves the way for further research into other pathogenic mechanisms across various forms of dementia, including vascular dementia.<\/p>\n

The lessons learned from Alzheimer’s research are invaluable for tackling other dementia types. For vascular dementia, ongoing research focuses on better understanding the underlying mechanisms of cerebrovascular damage, identifying novel therapeutic targets to improve blood flow to the brain, and developing interventions to repair damaged blood vessels. Clinical trials are exploring a range of strategies, from pharmacological agents to lifestyle interventions, aimed at preventing further damage and preserving cognitive function.<\/p>\n

Hilary Evans-Newton, Chief Executive of Alzheimer\u2019s Research UK, emphasized this crucial moment in research: \u201cThere has never been a more exciting time to support dementia research, as new treatments are finally on the horizon. But we must not lose momentum now \u2013 we must build on this progress to deliver a cure for every single person affected by dementia.\u201d Her statement reflects the collective sentiment within the scientific community: while progress is being made, sustained investment and public support are vital to translate promising discoveries into widespread clinical benefits.<\/p>\n

The Ripple Effect: Impact on Families and Caregivers<\/strong><\/p>\n

Dementia’s impact extends far beyond the individual diagnosed, creating a profound ripple effect throughout families and communities. Kola Bokinni’s observation that "Dementia doesn’t just affect the person who has the diagnosis, it affects the whole family" is a universally recognized truth. Family members often become the primary caregivers, taking on immense responsibilities that can be emotionally, physically, and financially draining.<\/p>\n

The provision of round-the-clock care, as required by Taiwo Bokinni, exemplifies the demanding nature of this role. Caregivers navigate a complex landscape of managing symptoms, assisting with daily activities, ensuring safety, and coping with the emotional distress of watching a loved one gradually lose their cognitive abilities and personality. This can lead to significant stress, anxiety, depression, and social isolation among caregivers, many of whom sacrifice their own careers, social lives, and well-being to provide care. Studies consistently show higher rates of mental health issues and reduced quality of life among dementia caregivers compared to the general population.<\/p>\n

The UK\u2019s National Health Service (NHS) and social care systems are under immense pressure to support this growing need. While professional care services exist, the majority of care for people with dementia is still provided informally by family and friends. This highlights the critical need for not only medical breakthroughs but also enhanced support systems for caregivers, including respite care, emotional counseling, and financial assistance.<\/p>\n

A Call to Action: Changing the Future of Dementia<\/strong><\/p>\n

Kola Bokinni\u2019s brave decision to share his family\u2019s story on World Alzheimer\u2019s Day serves as a powerful call to action. It transforms an abstract global health crisis into a deeply human narrative, compelling individuals to engage with the reality of dementia and the potential for change. Hilary Evans-Newton reiterated the gravity of the situation and the urgency of the mission: \u201cWe\u2019re incredibly grateful to Kola for bravely sharing the devastating impact of his father\u2019s dementia, in a selfless effort to change the ending for others. Tragically, Kola\u2019s story is one many families are being forced to live through today and, as it stands, no one survives dementia.\u201d<\/p>\n

Alzheimer\u2019s Research UK\u2019s Change The Ending<\/em> campaign is designed to be unapologetically honest, aiming to shock and motivate. \u201cWe know the film will be hard to watch, but by facing up to the harsh realities of this condition, we hope to make clear that now is the time to take action,\u201d Evans-Newton stated. The message is clear: dementia is not an inevitable part of aging, and it is not insurmountable. With concerted effort, sustained funding, and a collaborative spirit among researchers, policymakers, and the public, the trajectory of this devastating condition can be altered.<\/p>\n

The vision of Alzheimer’s Research UK, supported by advocates like Kola Bokinni, is to create a future where dementia is no longer a death sentence but a treatable, even preventable, condition. This future hinges on continued investment in scientific inquiry, fostering international collaboration, and translating research findings into accessible therapies. Bokinni\u2019s poignant story, set against the backdrop of a global awareness day and cutting-edge research, underscores that while the journey is arduous, the hope for a cure for every single person affected by dementia remains a powerful and achievable aspiration.<\/p>\n","protected":false},"excerpt":{"rendered":"

In a poignant and deeply personal revelation, Kola Bokinni, the acclaimed star of Apple TV+\u2019s Emmy and SAG Award-winning series Ted Lasso, has publicly shared the devastating impact of dementia…<\/p>\n","protected":false},"author":1,"featured_media":431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[4,6,3,7,5],"class_list":["post-432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alzheimers-dementia-research","tag-alzheimers","tag-brain-health","tag-dementia","tag-geriatric-medicine","tag-memory-loss"],"_links":{"self":[{"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/posts\/432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/comments?post=432"}],"version-history":[{"count":0,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/posts\/432\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/media\/431"}],"wp:attachment":[{"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/media?parent=432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/categories?post=432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forgetnow.com\/index.php\/wp-json\/wp\/v2\/tags?post=432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}